Camden Capital »

Vaneck Vectors Pharmaceutical etf shares owned by Camden Capital

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Camden Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $255k 2.8k 90.35
2025-06-30 $247k 2.8k 87.97
2025-03-31 $254k 2.8k 91.13

More positions owned by Camden Capital

NVIDIA Corporation Put Option (NVDA)
Onemain Holdings (OMF)
Citigroup Com New (C)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ge Aerospace Com New (GE)
Apple (AAPL)
Micron Technology (MU)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Microsoft Corporation (MSFT)
Bank of America Corporation (BAC)
Wells Fargo & Company (WFC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Flagstar Financial Com New (FLG)
PNC Financial Services (PNC)

View all positions for Camden Capital

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf